Femtobiomed Inc. (XKON:327610)
South Korea · Delayed Price · Currency is KRW 744.00
+58.00 (8.45%)
At close: Mar 5, 2026
Femtobiomed Market Cap
Femtobiomed has a market cap or net worth of 6.82 billion as of March 6, 2026. Its market cap has decreased by -85.04% in one year.
Market Cap
6.82B
Enterprise Value
n/a
Revenue
389.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
744.00
Market Cap Chart
Since July 10, 2019, Femtobiomed's market cap has decreased from 92.71B to 6.82B, a decrease of -92.64%. That is a compound annual growth rate of -32.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.82B | -72.16% |
| Dec 30, 2025 | 24.50B | -46.26% |
| Dec 30, 2024 | 45.59B | -0.75% |
| Dec 28, 2023 | 45.93B | -52.68% |
| Dec 29, 2022 | 97.06B | -34.72% |
| Dec 30, 2021 | 148.69B | 53.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 33.40B |
| MOA Life Plus | 26.61B |
| ADBiotech | 26.57B |
| Moogene Medi | 21.36B |
| Plumbline Life Sciences | 18.69B |
| OLIPASS | 8.40B |
| Angiolab | 7.59B |